After brokering the $10bn sale of the biotech company he led, Tony Coles planned to follow the well-trodden path of corporate high flyers who have shifted down a gear or two. “I wanted to take some time and think things through,” he says. “Spend time doing health policy consulting, or sitting on boards.”
在将自己领导的生物科技公司以约100亿美元的价格出售以后，托尼•科尔斯(Tony Coles)为自己规划了一条很多成功企业家在降低工作强度以后常常会选择的老路。他说：“我想花些时间将事情想清楚。将时间用于提供健康政策咨询或者在企业的董事会中担任职务。”
您已阅读5%（431字），剩余95%（8966字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。